Moderna Vaccine Provokes Strong Immune Response in Children 6 to 11 - The New York Times

Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.

The delay in authorization has been longest in the United States. Europes drug regulators approved Modernas vaccine for adolescents aged 12 to 17 last summer, and has recommended approval for childre… [+1246 chars]

full article...